157 related articles for article (PubMed ID: 38063077)
21. Breviscapine alleviates podocyte injury by inhibiting NF-κB/NLRP3-mediated pyroptosis in diabetic nephropathy.
Sun L; Ding M; Chen F; Zhu D; Xie X
PeerJ; 2023; 11():e14826. PubMed ID: 36815984
[TBL] [Abstract][Full Text] [Related]
22. High glucose-induced ubiquitination of G6PD leads to the injury of podocytes.
Wang M; Hu J; Yan L; Yang Y; He M; Wu M; Li Q; Gong W; Yang Y; Wang Y; Handy DE; Lu B; Hao C; Wang Q; Li Y; Hu R; Stanton RC; Zhang Z
FASEB J; 2019 May; 33(5):6296-6310. PubMed ID: 30785802
[TBL] [Abstract][Full Text] [Related]
23. Sp1-mediated upregulation of Prdx6 expression prevents podocyte injury in diabetic nephropathy via mitigation of oxidative stress and ferroptosis.
Zhang Q; Hu Y; Hu JE; Ding Y; Shen Y; Xu H; Chen H; Wu N
Life Sci; 2021 Aug; 278():119529. PubMed ID: 33894270
[TBL] [Abstract][Full Text] [Related]
24. EDA2R mediates podocyte injury in high glucose milieu.
Lan X; Kumar V; Jha A; Aslam R; Wang H; Chen K; Yu Y; He W; Chen F; Luo H; Malhotra A; Singhal PC
Biochimie; 2020 Jul; 174():74-83. PubMed ID: 32304771
[TBL] [Abstract][Full Text] [Related]
25. p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway.
Zheng D; Tao M; Liang X; Li Y; Jin J; He Q
Histol Histopathol; 2020 Apr; 35(4):405-415. PubMed ID: 31650524
[TBL] [Abstract][Full Text] [Related]
26. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
Ilatovskaya DV; Blass G; Palygin O; Levchenko V; Pavlov TS; Grzybowski MN; Winsor K; Shuyskiy LS; Geurts AM; Cowley AW; Birnbaumer L; Staruschenko A
J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963
[No Abstract] [Full Text] [Related]
27. Translationally controlled tumour protein is associated with podocyte hypertrophy in a mouse model of type 1 diabetes.
Kim DK; Nam BY; Li JJ; Park JT; Lee SH; Kim DH; Kim JY; Kang HY; Han SH; Yoo TH; Han DS; Kang SW
Diabetologia; 2012 Apr; 55(4):1205-17. PubMed ID: 22311416
[TBL] [Abstract][Full Text] [Related]
28. [Effects and mechanisms of Supplemented Gegen Qinlian Decoction Formula against podocyte pyroptosis and insulin resistance in model rats with diabetic kidney disease].
Wang MZ; Yue LJ; Wan YG; Huang H; Wu W; Tu Y; Liu BH; Fang QJ; Yuan CC; Wang J; Li H; Wan ZY
Zhongguo Zhong Yao Za Zhi; 2021 Sep; 46(17):4471-4479. PubMed ID: 34581052
[TBL] [Abstract][Full Text] [Related]
29. Autophagy is involved in regulating VEGF during high-glucose-induced podocyte injury.
Miaomiao W; Chunhua L; Xiaochen Z; Xiaoniao C; Hongli L; Zhuo Y
Mol Biosyst; 2016 Jun; 12(7):2202-12. PubMed ID: 27138352
[TBL] [Abstract][Full Text] [Related]
30. Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease.
Shahzad K; Fatima S; Khawaja H; Elwakiel A; Gadi I; Ambreen S; Zimmermann S; Mertens PR; Biemann R; Isermann B
Kidney Int; 2022 Oct; 102(4):766-779. PubMed ID: 35779608
[TBL] [Abstract][Full Text] [Related]
31. High glucose provokes microvesicles generation from glomerular podocytes via NOX4/ROS pathway.
Li M; Zhang T; Wu X; Chen Y; Sun L
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31664454
[TBL] [Abstract][Full Text] [Related]
32. Qizhi Jiangtang capsule activates podocyte autophagy in diabetic kidney disease by inhibiting phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin pathways.
Zhaoan G; Lina S; Yingying L; Ruifeng LI; Chong L; Ke D; Jing S; Jun S
J Tradit Chin Med; 2023 Aug; 43(4):667-675. PubMed ID: 37454251
[TBL] [Abstract][Full Text] [Related]
33. Repression of miR-217 protects against high glucose-induced podocyte injury and insulin resistance by restoring PTEN-mediated autophagy pathway.
Sun J; Li ZP; Zhang RQ; Zhang HM
Biochem Biophys Res Commun; 2017 Jan; 483(1):318-324. PubMed ID: 28017719
[TBL] [Abstract][Full Text] [Related]
34. Dihydroxyacetone phosphate signals glucose availability to mTORC1.
Orozco JM; Krawczyk PA; Scaria SM; Cangelosi AL; Chan SH; Kunchok T; Lewis CA; Sabatini DM
Nat Metab; 2020 Sep; 2(9):893-901. PubMed ID: 32719541
[TBL] [Abstract][Full Text] [Related]
35. Tangshenning Attenuates High Glucose-Induced Podocyte Injury via Restoring Autophagy Activity through Inhibiting mTORC1 Activation.
Xu J; Shan X; Chen C; Gao Y; Zou D; Wang X; Wang T; Shi Y
J Diabetes Res; 2022; 2022():1610416. PubMed ID: 35799948
[TBL] [Abstract][Full Text] [Related]
36. Tanshinone IIA mediates protection from diabetes kidney disease by inhibiting oxidative stress induced pyroptosis.
Wu Q; Guan YB; Zhang KJ; Li L; Zhou Y
J Ethnopharmacol; 2023 Nov; 316():116667. PubMed ID: 37257702
[TBL] [Abstract][Full Text] [Related]
37. C1-Ten is a PTPase of nephrin, regulating podocyte hypertrophy through mTORC1 activation.
Lee J; Koh A; Jeong H; Kim E; Ha TS; Saleem MA; Ryu SH
Sci Rep; 2017 Sep; 7(1):12346. PubMed ID: 28955049
[TBL] [Abstract][Full Text] [Related]
38. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
39. Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy.
Salemkour Y; Yildiz D; Dionet L; 't Hart DC; Verheijden KAT; Saito R; Mahtal N; Delbet JD; Letavernier E; Rabant M; Karras A; van der Vlag J; Nijenhuis T; Tharaux PL; Lenoir O
J Am Soc Nephrol; 2023 Nov; 34(11):1823-1842. PubMed ID: 37678257
[TBL] [Abstract][Full Text] [Related]
40. FOXM1-activated SIRT4 inhibits NF-κB signaling and NLRP3 inflammasome to alleviate kidney injury and podocyte pyroptosis in diabetic nephropathy.
Xu X; Zhang L; Hua F; Zhang C; Zhang C; Mi X; Qin N; Wang J; Zhu A; Qin Z; Zhou F
Exp Cell Res; 2021 Nov; 408(2):112863. PubMed ID: 34626587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
